Thales Builds Cryptographic Security for the Age of AI and Post-Quantum Computing
14.9.2026 09:00:00 CEST | Business Wire | Press release
Thales launches Luna 8, a new hardware security module (HSM) to provide future-ready, quantum resistant security to protect critical data and applications Powered by a Thales designed cryptographic processor, it delivers unparalleled performance, enhanced protection and the flexibility to adapt to new security needs Drawing on decades of cryptographic expertise, Luna 8 combines trusted security with support for emerging technologies, including post quantum cryptography
According to the 2026 Thales Data Threat Report, the threat of Harvest Now, Decrypt Later (HNDL) attacks was the top-cited risk, with 59% of organizations reporting that they are prototyping and evaluating post-quantum cryptography (PQC) algorithms to prepare for the quantum era.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804748922/en/

©Thales
To help organizations turn this readiness into deployment,Thales, a global leader in advanced technologies, today announced the launch of Luna 8, its next-generation hardware security module. Designed for the transition to post-quantum cryptography, Luna 8 enables organizations to securely store, protect, and manage cryptographic keys with market-leading performance, scalability, and speed.
As organizations face growing pressure from emerging quantum threats, expanding AI workloads and evolving stringent regulatory requirements, Luna 8 provides the performance, security and cryptographic agility needed to protect sensitive data, applications and digital identities.
“The risks that quantum computing poses to encryption standards are unprecedented,” said Todd Moore, VP of Data Security Products at Thales. “Enterprises need to build post-quantum readiness through cryptographic agility. Powered by our custom-designed cryptographic processor, Luna 8 delivers high-performance support for both current and post-quantum algorithms, while helping customers maintain control over security.”
“The new quantum-safe HSM from Thales enables us to support multiple secure environments while simplifying operations and making more efficient use of our infrastructure,” said Jack Zhou, CIO at HKVAX. “The flexibility to support multiple use cases, applications and business needs over time helps us maximize hardware investments. The combination of predictable performance and high availability gives our IT and security teams the assurance they need to operate efficiently to deliver consistent service to our stakeholders.”
“Integration, automation and scalability are increasingly important considerations for organizations modernizing their cryptographic infrastructure,”said Michela Menting, Vice President, Research, at ABI Research.“Luna 8 combines support for post-quantum cryptography with the flexibility organizations need to adapt as security requirements constantly evolve.”
Key advantages of the Luna 8 HSM include:
- Quantum readiness: Luna 8 secures the cryptographic keys underpinning critical enterprise services such as PKI, certificate management, authentication, digital signing and identities; while providing a seamless path to post-quantum cryptography without disrupting existing investments.
- Performance: With orders of magnitude faster cryptographic operations, Luna 8 delivers the performance needed for the most demanding applications.
- Scalability: It scales effortlessly from enterprise deployments to hyperscale environments, supporting rapidly growing cryptographic workloads without compromise.
- Future-proof: Its upgradeable architecture makes it easy to introduce new algorithms, standards, and capabilities, ensuring it remains secure, adaptable, and future-ready for years to come.
- Portability: Seamless migration for existing customers as it uses the same ancillaries and interfaces without requiring changes to current applications.
- Flexibility: Luna 8 is delivered on a unified hardware appliance designed to support a variety of cryptographic applications. Future releases will also support payShield 11K, extending the platform to payment HSMs that protect payment transactions, PINs and sensitive cryptographic keys used by banks and payment providers worldwide.
Luna 8 is the first next-generation HSM on the new Thales HSM platform. Available now as a network appliance, it provides quantum-safe, tamper-resistant security with scalable performance. Designed for the highest assurance requirements, Luna 8 is being independently assessed to meet some of the world’s most demanding security standards (including FIPS 140-3 Level 3 and EU Common Criteria).
Find out more about the technical specifications of Luna 8 here or join our webinar here.
Read more about Thales’ expertise in post-quantum cryptography:
- Why post-quantum cryptography matters for digital identity
- How to safeguard mobile connectivity in a post-quantum world
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies for the Defence, Aerospace, and Cyber & Digital sectors. Its portfolio of innovative products and services helps address several major challenges: sovereignty, security, sustainability and inclusion.
The Group allocates €4.5 billion per year in Research & Development in key areas, particularly for critical environments, such as Artificial Intelligence, Cybersecurity, Quantum and Cloud technologies. Thales has more than 85,000 employees in 65 countries. In 2025, the Group generated sales of €22.1 billion.
Recent images of Thales and its Defense, Aerospace and Cyber & Digital activities can be found on the Thales Media Library. For any specific requests, please contact the Media Relations team.
PLEASE VISIT
Thales Group
Cybersecurity Products | Thales Group
Cybersecurity Solutions | Thales Group
View source version on businesswire.com: https://www.businesswire.com/news/home/20260804748922/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations14.9.2026 09:00:00 CEST | Press release
Acceptance is based on pivotal Phase 3 data demonstrating rapid, durable and consistent skin clearance, including in high-impact sites, in a convenient once-daily pill Results from nearly 3,000 patients support potential for next-generation TYK2 inhibitor to redefine oral treatment expectations in psoriasis The Prescription Drug User Fee Act (PDUFA) target action date is in the first quarter of calendar year 2027 Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) under Priority Review for zasocitinib (TAK-279) for the treatment of adults with moderate-to-severe plaque psoriasis. Zasocitinib is an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, which demonstrated rapid, durable and consistent skin clearance in Phase 3 plaque psoriasis studies.1-3 Addressing unmet needs in psoriasis treatment “Despite progress in psoriasis care, there remains a need for highly
SWISSto12 and Mitsubishi Electric Corporation Announce Strategic Partnership14.9.2026 09:00:00 CEST | Press release
The Memorandum of Understanding (MoU) and additional contract signal a new phase of collaboration on market development in the Asia Pacific (APAC) region SWISSto12 today announced a memorandum of understanding (MoU) with Mitsubishi Electric Corporation (MELCO) (TOKYO: 6503) to pursue joint opportunities on advanced payloads, radio frequency (RF) products, and market development in Japan and the APAC region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914982179/en/ Masahiko Arai, Executive Officer and Group President, Defense & Space Systems, Mitsubishi Electric, and Dr. Emile de Rijk, Chief Executive Officer, SWISSto12 Joint opportunities will leverage MELCO’s extensive satellite system expertise and integration capabilities together with SWISSto12’s proprietary 3D-printing designs and processes that form the foundation of its next-generation payloads—smaller, lighter, highly performant, yet built in materially shorter
Focused Support Launches Cavok STRIKE to Expand Link-16 Participation Across the Joint Force14.9.2026 07:00:00 CEST | Press release
Extending Link-16 interoperability without platform-level hardware integration Focused Support LLC today announced the launch of Cavok STRIKE, an integrated software capability that expands the Link-16 tactical battlespace picture by enabling additional operational platforms to participate in the Link-16 network. Modern battlefields have increasing numbers of unmanned systems, sensors, and supporting platforms operating throughout the joint battlespace. The rapid proliferation of Group 1, 2, and 3 UAS, including both expendable and recoverable systems, has created a growing need to integrate these assets into the broader tactical network. Many of these platforms provide operationally relevant information but have historically remained outside the Link-16 network due to limitations in size, weight, power, platform integration complexity, or acquisition cost. Cavok STRIKE addresses this gap by enabling platforms to participate in the Link-16 network as non-command-and-control participant
Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma14.9.2026 07:00:00 CEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted market authorization for the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays for use on the fully automated LUMIPULSE® G immunoassay platform in Brazil. “ANVISA authorization of the Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma assays marks another important step in our mission to expand access to reliable, clinically meaningful blood-based biomarkers for clinicians and patients worldwide,” said Christiaan De Wilde, CEO of Fujirebio Europe N.V. “By making both neurological biomarker assays available to laboratories on a single, fully automated platform, we are helping support more informed clinical decision-making across a broad range of neurological conditions and throughout the diagnostic pathway.” The Brazilian ANVISA authorizations are based on the already CE marked in vitro diagnostics (IVD) approvals of these two
MEX Exchange, Part of MultiBank Group, Expands Executive Team as International Growth Accelerates14.9.2026 07:00:00 CEST | Press release
• Brian Liedberg joins MEX Exchange, bringing more than 30 years of experience across global capital markets, electronic trading and FinTech MEX Exchange, the institutional electronic trading platform of MultiBank Group, has announced the appointment of Brian Liedberg as Chief Revenue Officer and Global Head of Sales, strengthening its commercial leadership as the company continues to develop its institutional trading business and expand its presence across international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260913319267/en/ Brian Liedberg joins MEX Exchange, bringing more than 30 years of experience across global capital markets, electronic trading and FinTech Liedberg brings more than 30 years of experience across global capital markets, electronic trading and financial technology, with a career spanning institutional sales, business development, commercial strategy and revenue growth. Prior to joining ME
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom